Moreover, upstream regulatory mechanisms of IGF2BPs were scarcely investigated in AML, while we found that IGF2BP2 and IGF2BP3 were driven by SEs, highlighting a novel and potential modulatory pattern of m6A‐binding proteins. Here, IGF2BP2 is linked to acute myeloid leukemia.